Results 111 to 120 of about 48,572 (243)

Pheochromocytoma Crisis Treated with Urapidil: a Case Report

open access: yesActa Clinica Croatica
Pheochromocytomas are rare tumors that present with a broad spectrum of symptoms and signs, making differential diagnosis broad. They can cause a pheochromocytoma crisis that manifests with arterial blood pressure oscillations, and subsequent symptoms ...
Miro Bakula   +5 more
doaj   +1 more source

Catecholamine induced cardiomyopathy in pheochromocytoma

open access: yes, 2013
Catecholamine induced cardiomyopathy in the setting of pheochromocytoma is an unusual clinical entity. Earlier studies have reported left ventricular dysfunction in around 10% of subjects with pheochromocytoma. [1] Catecholamine induced vasoconstriction,
Thomas V Paul   +5 more
core   +1 more source

Oncocytoma Arising From an Accessory Adrenal Gland: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Accessory adrenal oncocytomas are rare. Consequently, the clinical characteristics and management of this entity remain poorly defined. Case Presentation A 65‐year‐old man presented with a retroperitoneal mass. Imaging revealed a 103 × 96 mm tumor adjacent to the left kidney.
Yuki Seki   +9 more
wiley   +1 more source

Perioperative Blood Pressure Control in Pheochromocytoma: The Role of Intravenous Urapidil

open access: yes
Pheochromocytomas are rare tumors derived from chromaffin cells of neural crest origin in the adrenal medulla. These neoplasms typically synthesize and secrete catecholamines. Excessive secretion of catecholamines can lead to severe and potentially fatal
Levent Özsarı, Egemen Tural
core   +1 more source

Cardiovascular Manifestations of Pheochromocytoma

open access: yes, 2017
Pheochromocytomas are rare endocrine tumors that can have a significant impact on a variety of organ systems, including the cardiovascular system. Although the pathophysiology is not completely understood, pheochromocytomas exert their effects through ...
Poste, J   +9 more
core   +1 more source

Preoperative Diagnosis of Bladder Paraganglioma Followed by Robot‐Assisted Partial Cystectomy: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Bladder paraganglioma is a rare neuroendocrine tumor for which accurate preoperative diagnosis is important because tumor manipulation may provoke catecholamine‐related hemodynamic instability. Case Presentation A 58‐year‐old man presented with hematuria. Cystoscopy revealed a submucosal bladder tumor.
Kimiaki Takagi   +4 more
wiley   +1 more source

PASSIONS AROUND PHEOCHROMOCYTOMA [PDF]

open access: yes, 2016
A clinical case of arterial hypertension (AH) in patient with family history of pheochromocytoma is described. Patient has no classical clinical signs and imaging phenotype of pheochromocytoma, but there are a number of warnings – family history of ...
O. V. Petrenko   +3 more
core  

Unusual presentation of pheochromocytoma

open access: yes, 2014
Pheochromocytomas are rare catecholamine-secreting tumors that arise from chromaffin tissue within the adrenal medulla and extra-adrenal sites. Due to the excess secretion of hormones, these tumors often cause debilitating symptoms and a poor quality-of ...
Rajendra B. Nerli   +4 more
core   +1 more source

Pheochromocytoma: A Brief Review

open access: yes, 2001
Pheochromocytoma, a rare tumor, can cause one of the most dramatic, life-threatening crises in the medical field of endocrinology. This catecholamine-producing tumor can occur from infancy to old age and may be associated with pregnancy.
Linda G. Tolstoi
core   +1 more source

Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
The graphical abstract represents the underlying neuroprotective potential of ICS II against Alzheimer's disease, Cerebral ischemia and Parkinson disease. ICS II downregulates ROS production, inflammation, mitochondrial dysfunction and apoptosis along with regulating their key signalling pathways.
Ashutosh Solanki   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy